Norvegija - norvegų - Statens legemiddelverk

bela-pharm gmbh & co. kg - glukosemonohydrat - infusjonsvæske, oppløsning - 40 g/100 ml

Europos Sąjunga - norvegų - EMA (European Medicines Agency)

hipra human health s.l. - sars-cov-2 virus recombinant spike (s) protein receptor binding domain (rbd) fusion heterodimer – b.1.351-b.1.1.7 strains - covid-19 virus infection - vaksiner - bimervax is indicated as a booster for active immunisation to prevent covid-19 in individuals 16 years of age and older who have previously received a mrna covid-19 vaccine.